EYPT compared with BNTC: revenue, margins and what each company keeps, and the suppliers and customers both name

EYPTEyePoint, Inc.

Mkt capRevenueRevenue

BNTCBenitec Biopharma Inc.

Mkt capRevenueRevenue

Compare

EYPTEyePoint, Inc.

BNTCBenitec Biopharma Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

EYPT

1 of 4at or beyond implied

Reportimpliedrealized× implied

Oct 19 '26±69.4%▼−85.28%×1.23

Q2 FY26±51.1%▲+4.97%×0.10

May 6 '26±12.1%▼−2.91%×0.24

Q1 FY26±13.6%▼−1.75%×0.13

BNTC

0 of 4at or beyond implied

Reportimpliedrealized× implied

Sep 15 '26±33.9%▼−8.53%×0.25

Q3 FY26±46.8%▲+1.72%×0.04

= impliedEYPT realized, solidBNTC realized, hatchedOne scale, both sides: full bar = 86%× = |realized| ÷ impliedSource: market data

Feb 12 '26

±42.4%

▼−2.66%

×0.06

Nov 17 '25±33.2%▲+2.81%×0.08

EYPTEyePoint, Inc.

0.39▲+3.52%

Mkt cap$32.3MRevenue$507,000Q2 FY26Revenue$31MFY25

BNTCBenitec Biopharma Inc.

8.50▲+0.16%

Regular sessionNov 3 '26

Mkt cap$296.2MRevenue$7,000Q4 FY23Revenue—

Compare

Regular sessionNov 3 '26

EYPTEyePoint, Inc.

BNTCBenitec Biopharma Inc.

0.39▲+3.52%

Price

8.50▲+0.16%

$32.3M

Mkt cap

$296.2M

Q2 FY26$507,000

Revenue

$7,000Q4 FY23

FY25$31M

Revenue

—

EYPT0.39▲+3.52%vsBNTC8.50▲+0.16%Regular sessionNov 3 '26